SYSTEMATIC REVIEW article

Front. Med., 30 October 2017

Sec. Infectious Diseases: Pathogenesis and Therapy

Volume 4 - 2017 | https://doi.org/10.3389/fmed.2017.00183

Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment

  • Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, United States

Abstract

Background:

Drug-resistance genes found in human bacterial pathogens are increasingly recognized in saprophytic Gram-negative bacteria (GNB) from environmental sources. The clinical implication of such environmental GNBs is unknown.

Objectives:

We conducted a systematic review to determine how often such saprophytic GNBs cause human infections.

Methods:

We queried PubMed for articles published in English, Spanish, and French between January 2006 and July 2014 for 20 common environmental saprophytic GNB species, using search terms “infections,” “human infections,” “hospital infection.” We analyzed 251 of 1,275 non-duplicate publications that satisfied our selection criteria. Saprophytes implicated in blood stream infection (BSI), urinary tract infection (UTI), skin and soft tissue infection (SSTI), post-surgical infection (PSI), osteomyelitis (Osteo), and pneumonia (PNA) were quantitatively assessed.

Results:

Thirteen of the 20 queried GNB saprophytic species were implicated in 674 distinct infection episodes from 45 countries. The most common species included Enterobacter aerogenes, Pantoea agglomerans, and Pseudomonas putida. Of these infections, 443 (66%) had BSI, 48 (7%) had SSTI, 36 (5%) had UTI, 28 (4%) had PSI, 21 (3%) had PNA, 16 (3%) had Osteo, and 82 (12%) had other infections. Nearly all infections occurred in subjects with comorbidities. Resistant strains harbored extended-spectrum beta-lactamase (ESBL), carbapenemase, and metallo-β-lactamase genes recognized in human pathogens.

Conclusion:

These observations show that saprophytic GNB organisms that harbor recognized drug-resistance genes cause a wide spectrum of infections, especially as opportunistic pathogens. Such GNB saprophytes may become increasingly more common in healthcare settings, as has already been observed with other environmental GNBs such as Acinetobacter baumannii and Pseudomonas aeruginosa.

Introduction

In 2013, the Centers for Disease Control and Prevention released a report “Antibiotic Resistance in the United States, 2013” that classified groups of drug-resistant microorganisms into “urgent threat,” “serious threat,” and “concerning threat” pathogens (1). Drug-resistant Gram-negative bacterial (GNB) pathogens comprised 2 of the 3 “urgent threat” pathogens and 7 of 12 “serious threat” pathogens (1). GNBs cause about one-third of healthcare-associated (HCA) infections in the United States, and the proportion of multidrug-resistant and non-fermentative organisms (Pseudomonas aeruginosa, Acinetobacter baumannii) causing these infections has increased dramatically in the last 20 years, according to the National Healthcare Safety Network (NHSN) surveys (2). While still relatively low in most hospitals in the United States, multidrug-resistant Acinetobacter baumannii, an environmental saprophyte, has become endemic in healthcare settings in several Latin American countries, and has surpassed P. aeruginosa as the most common non-fermentative GNB in such settings (3). The progressive increase in drug resistance and new species of GNBs causing HCA infections may represent an evolution in drug-resistant GNB infections that may profoundly affect the future landscape of epidemiology and clinical management of such infections in the healthcare environment globally.

Most of the new antimicrobial drug-resistance mechanisms discovered during the last 20 years have been those found in GNBs (4–11). In 2011, Raphael et al. reported identification of a variety of saprophytic GNB species on retail spinach that were resistant to antimicrobial agents commonly used in clinical settings (12). Twelve of 20 species found on spinach expressed extended-spectrum β-lactamases (ESBLs), based on their resistance to ceftazidime and cefotaxime (12). Two strains of Pseudomonas putida and one strain of Pseudomonas teessidea contained blaCTX-M-15, the most common ESBL gene distributed globally and carried frequently by the most common pandemic extraintestinal pathogenic E. coli (ExPEC) lineage ST131 (13–17). They suggested that environmental saprophytes may serve as a reservoir for some of the common drug-resistance genes found in human GNB pathogens (12).

Saprophytes are environmental microorganisms that survive on dead organic matter. While no pathogenic GNB organisms were found on spinach in the above study, we were concerned that a large proportion of these saprophytic organisms were drug resistant. We wished to know whether saprophytic GNBs that carry recognized drug-resistance genes cause human infections. After all, pathogenic GNBs, such as K. pneumoniae, P. aeruginosa, and Acinetobacter spp., are environmental GNB organisms. Here, we conducted a systematic bibliographic search of human infections caused by well-recognized environmental saprophytic GNB species. We present our review results and suggest that these saprophytic GNB may represent a harbinger of the next phase of the evolution of GNB infections, especially in healthcare settings.

Methods

Data Sources and Searches

We followed the guideline outlined in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) to conduct this review (Figure 1). Using the names of GNB species listed in Table 1 as search terms, we queried PubMed for abstracts and full-length articles that were published in English, French, and Spanish between January 2006 and July 2014. The selected GNB species were based on those frequently found on retail spinach in a previous report (1). If more than 200 articles appeared for one species, the term “infections” was added to the search. In certain cases, the term “human infections” or “hospital infection” was added. If an organism was not reported as a cause of human infection after 2006, the search was widened to include articles published before 2006.

Figure 1

Table 1

OrganismCase reports (cases)Hospital-based microbiological surveys (isolates)Countries reporting infectionReference
Acinetobacter rhizosphaerae00
Enterobacter aerogenes/Klebsiella aerogenes24 (27)87 (7,498)Japan, Nigeria, US, Belgium, Taiwan, Italy, China, Korea, Portugal, France, Sri Lanka, Spain, Belgium, Switzerland, UK, Indonesia, Brazil, India, Greece, Saudi Arabia, Canada, Philippines, Austria, Costa Rica, Bulgaria, Kazakhstan, Turkey, Fiji, Ivory Coast, Netherlands, Australia, Gran Canaria, Nepal, Nigeria, Venezuela, Germany(13, 18–128)
Enterobacter amnigenus6 (8)2 (6)China, India, US, Italy, France, Spain(105, 129–136)
Enterobacter asburiae2 (2)9 (108)US, Korea, Switzerland, Norway, Portugal, Germany, Nigeria(33, 47, 68, 82, 137–143)
Enterobacter kobei1 (1)3 (20)Germany, Poland, Switzerland, Japan(33, 144–147)
Enterobacter ludwigii1 (1)1 (3)India, Germany(144, 145, 148)
Erwinia persicina/persicinus1 (1)0US(149)
Erwinia rhapontici00
Pantoea agglomerans/Enterobacter agglomerans37 (56)13 (154)Spain, US, Belgium, Taiwan, Italy, Kuwait, Korea, France, UK, Netherlands, India, Israel, Canada, Germany, Turkey, Brazil, Zimbabwe, Mexico, Bulgaria, Nigeria, Greece, Malaysia(6, 47, 58, 63, 70, 79, 150–191)
Pantoea ananatis2 (2)2 (8)Tunisia, India, Belgium, Georgia(192–195)
Pseudomonas fragi00
Pseudomonas libanensis00
Pseudomonas orientalis00
Pseudomonas putida13 (29)19 (176)Japan, Spain, Iraq, US, Turkey, US–Hawaii, UK, Brazil, Poland, Taiwan, Italy, Belgium, Korea, France, Argentina, China, Canary islands(59, 189, 196–225)
Pseudomonas reactans00
Pseudomonas rhodesiae00
Pseudomonas teessidea00
Pseudomonas syringae00
Rahnella aquatilis13 (15)1 (1)France, Spain, Japan, Switzerland, Greece, Germany, Saudi Arabia, US, Korea, Italy, Belgium(183, 224, 226–237)
Rhizobium spp.21 (24)0UK, Turkey, India, Japan, Belgium, US, Greece, Kuwait, Colombia, France, Taiwan, Italy, Venezuela, Spain, Portugal(90, 238–257)
Serratia fonticola4 (4)1 (1)France, Canada, Switzerland(133, 258–261)
Serratia proteamaculans2 (5)0France, US(262, 263)

Case reports and hospital microbiological surveys reporting infections caused by saprophytic Gram-negative bacteria (GNB) species previously identified on retail spinach [Raphael et al (12)].

Study Selection

We first identified 1,350 abstracts. After duplicates were removed, we reviewed 1,275 abstracts (Figure 1). We excluded for analysis abstracts, as well as reviews and microbiology papers that did not include human clinical data, or articles that described only episodes of colonization, laboratory contamination, or pseudo-infection (e.g., line or catheter contamination). Full-text articles were not available for 67 of these abstracts. We identified 355 abstracts after exclusion and obtained full-text articles for 288 of them. Of the full-text articles, 37 were excluded further due to incomplete GNB speciation and non-standard microbiologic test procedures reported in the articles. We, thus, included 251 articles for this review (18–76, 78–103, 105–245, 247–246); of these, 124 were case series reports and 127 were hospital microbiologic survey reports.

Data Extraction

We analyzed the selected articles for the GNB species implicated as causative agents of infections that were most commonly reported among the articles—blood stream infection (BSI), urinary tract infection (UTI), skin and soft tissue infection (SSTI), post-surgical infection (PSI), osteomyelitis (Osteo), and pneumonia (PNA). Other reported infections were grouped under the “other” category. The reports were also reviewed for descriptions of mortality, comorbidity, as well as healthcare interventions associated with the above infectious disease episodes. Finally, we reviewed microbiologic reports that accompanied these articles for drug-susceptibility test results as well as genetic analyses of drug-resistance determinants.

Quality Assessment

To assure search completeness and reproducibility of our findings, we conducted the same search described above on three different occasions—in 2011, 2013, and 2015. We included articles only from peer-reviewed journals. We reviewed in detail the descriptions of microbiologic test procedures used to detect and identify the implicated GNB species. We also examined the descriptions of drug-susceptibility test procedures to ascertain their standardization. Both authors ER and LR independently reviewed the quantitative data analysis results obtained from examination of these 251 articles.

Data Synthesis and Analysis

We first quantified the type and number of GNB species implicated in infections reported in the 251 selected articles. We then examined the frequencies of GNB species associated with the six most common infections described in the articles, separated by case series and hospital survey studies, reported from different regions of the world. We compared mortality and comorbidities associated with each of these infections and assessed unusual events that were described to trigger these infectious disease episodes. We then analyzed the microbiologic data, which included antimicrobial drug-susceptibility test results and PCR-based and nucleic acid sequence-based detection of drug-resistance genes.

Results

A previous study identified 20 distinct saprophytic GNB species among 231 randomly selected colonies cultured on MacConkey agar plates from 25 batches of retail spinach rinsates (12). Here, these 20 species were queried in the bibliographic search engines. Thirteen of these species were reported to cause human infections in the reviewed literature (Table 1). We identified 175 cases described in 124 separate case report series. From 127 hospital microbiology surveys, 7,671 isolates from infected subjects were reported. These infections were reported from 48 countries. The most commonly reported GNB species was Enterobacter aerogenes. E. aerogenes together with Pantoea agglomerans (formerly Enterobacter agglomerans) and Pseudomonas putida together comprised more than half of the reported cases of infection caused by these saprophytic GNBs.

The most commonly isolated GNB species reported from 127 hospital-based microbiologic surveys was also Enterobacter aerogenes; 7,498 E. aerogenes isolates from 87 separate hospital surveys were reported (Table 1). In both case series and hospital survey reports, the most common GNB species were identical—E. aerogenes, P. putida, P. agglomerans, and E. asburiae.

The bibliographic search identified 674 individuals who were diagnosed with infection caused by the 13 GNB species. These saprophytes caused a wide spectrum of infections (Table 2). They were isolated from 443 patients with BSI, 48 patients with SSTI, 36 patients with UTI, 28 patients with PSI, 21 patients with PNA, 16 patients with Osteo, and 82 with other infections. In addition to blood, urine, skin and soft tissue, surgical wounds, bone, and lungs, these GNB species were isolated from many other body sites such as the peritoneum, eyes, and the central nervous system (Table S1 in Supplemental Material).

Table 2

OrganismNumber of cases (deaths, cases with no underlying medical condition)
BSIUTIPSISSTIOsteoPNAOther
Enterobacter aerogenes232 (28, 0)7 (1, 0)3 (0, 0)6 (1, 1)3 (1, 1)1 (0, 0)17 (1, 1)
Enterobacter amnigenus3 (2, 0)001 (0, 1)004 (0, 1)
Enterobacter asburiae16 (0, 0)17 (0, 0)3 (0, 0)10 (0, 0)010 (0, 0)5 (0, 0)
Enterobacter kobei1 (0, 0)1 (0, 0)1 (0, 0)0000
Enterobacter ludwigii01 (0, 0)1 (0, 0)0001 (0, 0)
Erwinia persicina01 (0, 0)00000
Pantoea agglomerans67 (12, 1)4 (0, 0)025 (0, 2)12 (0, 1)2 (0, 0)30 (1, 3)
Pantoea ananatis1 (0, 0)000002 (0, 1)
Pseudomonas putida98 (14, 1)3 (0, 1)15 (4, 1)3 (1, 1)07 (2, 0)6 (0, 2)
Rahnella aquatilis10 (0, 1)2 (0, 0)3 (0, 0)0003 (0, 1)
Rhizobium spp.14 (0, 1)02 (0, 0)01 (0, 0)09 (0, 1)
Serratia fonticola1 (0, 0)003 (0, 1)001 (0, 0)
Serratia proteamaculans000001 (1, 0)4 (0, 0)
Total443 (56, 4)36 (1, 1)28 (4, 1)48 (2, 6)16 (2, 1)21 (3, 0)82 (2, 10)

Infections caused by saprophytic Gram-negative bacteria organisms.

BSI, blood stream infection; UTI, urinary tract infection; PSI, post-surgical infection; SSTI, skin and soft tissue infection; Osteo, osteomyelitis; PNA, pneumonia.

The most frequently isolated GNB species cultured from blood were E. aerogenes (232 cases), P. putida (98 cases), and P. agglomerans (67 cases). They were responsible for 89% of the BSI cases caused by the 13 saprophytic GNB species. Mortality from BSI associated with these organisms was 12, 14, and 18%, respectively. All of the patients with BSI, except 4, had comorbidities or underlying medical problems (Table 3 and supplemental table). The most common comorbidities associated with E. aerogenes BSI were cancer (35 cases), biliary disease (21 cases), acute respiratory distress syndrome (ARDS) (10 cases), premature birth (10 cases), and diabetes (9 cases). Many of these patients had an invasive procedure, chemotherapy, or immunosuppressive drugs within 14 days of the bacteremia. Of these BSI cases, 49 were reported as nosocomial infections.

Table 3

OrganismInfectionCVDPulmonaryGIDM-EndocrineGUOB-GYNGeneticRheumatologicNeurologicHeme-OncologicImmunologicMSKNeonatal diseasePsych and PSAOther infections
Enterobacter aerogenesBlood stream infection (BSI)✓✓✓✓✓✓✓✓✓✓✓
Urinary tract infection (UTI)✓✓✓✓✓✓✓✓
Post-surgical infection (PSI)
Skin and soft tissue infection (SSTI)✓✓✓✓
Osteomyelitis (Osteo)✓✓
Pneumonia (PNA)✓✓
Others✓✓✓✓✓✓✓✓✓✓
Enterobacter amnigenusBSI✓✓✓
SSTI
Others✓✓✓
Enterobacter asburiaeBSI✓✓✓✓
UTI✓✓
PSI
SSTI✓
PNA✓
Others
Enterobacter kobeiBSI✓✓
UTI✓✓
PSI✓✓
Enterobacter ludwigiiUTI
PSI✓
Others
Erwinia persicinaUTI✓✓✓
Pantoea/Enterobacter agglomeransBSI✓✓✓✓✓✓✓✓✓✓✓✓
UTI✓✓✓✓✓✓
PSI
SSTI✓✓✓✓✓✓
Osteo✓✓✓✓✓
PNA✓✓✓✓✓✓✓
Others✓✓✓✓✓✓✓✓✓✓✓✓
Pantoea ananatisBSI✓✓✓✓✓
Others✓✓
Pseudomonas putidaBSI✓✓✓✓✓✓✓✓✓✓✓✓
UTI✓✓✓
PSI✓✓✓✓✓✓
SSTI✓✓✓✓✓
PNA✓✓✓✓✓✓✓
Others✓✓✓✓
Rahnella aquatilisBSI✓✓✓✓✓✓✓✓✓
UTI✓✓✓✓✓
PSI✓✓✓✓
Others✓✓✓
Rhizobium spp.BSI✓✓✓✓✓✓✓✓✓✓
PSI✓✓✓✓
Osteo✓
Others✓✓✓✓✓✓✓✓
Serratia fonticolaBSI✓
SSTI✓
Others
Serratia proteamaculansPNA✓✓
Others✓

Comorbidities associated with infections caused by saprophytic Gram-negative bacteria species.

CVD, cardiovascular disease; GI, gastrointestinal disease; DM, diabetes mellitus; GU, genitourinary disease; OB-GYN, obstetrics-gynecology disease; MSK, musculoskeletal disease; PSA, polysubstance abuse.

The most common comorbidity associated with P. putida BSI were solid (31 cases) and hematologic (7 cases) malignancies (Table 3 and supplemental table). Contaminated central venous catheter (CVC), catheter lock infused with heparin, and other short-term intravascular devices were implicated with BSI in a large proportion of these patients (Table 4 and supplemental table).

Table 4

OrganismInfectionOrtho/trauma surgeryInterventional cardiologic proceduresTransplantNeurosurgeryGI proceduresOther surgeryChemotherapyCentral venous catheterCCPD/HDFoley catheterMechanical ventilationTransfusion/infusion
Enterobacter aerogenesBlood stream infection (BSI)✓✓✓✓✓✓
Urinary tract infection (UTI)✓
Post-surgical infection (PSI)✓✓
Skin and soft tissue infection (SSTI)✓✓
Osteomyelitis (Osteo)✓
Pneumonia (PNA)✓
Others✓✓✓
Enterobacter amnigenusBSI✓✓
Enterobacter asburiaePSI✓✓
Enterobacter kobeiBSI✓
UTI✓
PSI✓
Pantoea/Enterobacter agglomeransBSI✓✓✓✓✓
Osteo✓
PNA✓
Others✓✓✓
Pantoea ananatisBSI✓
Pseudomonas putidaBSI✓✓✓✓✓✓✓✓✓
UTI✓✓✓
PSI✓✓✓✓✓
SSTI✓✓
PNA✓✓✓
Others✓✓✓
Rahnella aquatilisBSI✓✓✓✓
UTI✓
PSI✓✓✓
Rhizobium spp.BSI✓✓✓✓✓✓✓✓
PSI✓✓
Others✓✓✓✓
Serratia fonticolaBSI✓
SSTI✓
Serratia proteamaculansPNA✓✓
Others✓

Healthcare-associated interventions associated with infections caused by saprophytic Gram-negative bacteria species.

Patients with P. agglomerans BSI also had a wide variety of underlying medical conditions and comorbidities, but no single group of comorbidity, such as cancer, was predominant, as they were with E. aerogenes and P. putida BSI (Table 3 and supplemental table). Contaminated CVCs, however, were commonly associated with BSI in this group also (Table 4 and supplemental table).

Interestingly, the frequency of types of infection varied according to GNB species. As described above, more than 80% of BSIs were caused by just three of the saprophytic GNBs—E. aerogenes, P. putida, and P. agglomerans. On the other hand, just two species—P. agglomerans (25 cases) and Enterobacter asburiae (10 cases)—accounted for 73% of the 48 SSTI cases. More than half of the 36 UTI cases were caused by E. asburiae. E. asburiae (10 cases) and P. putida (7 cases) were associated with 81% of the 21 PNA cases, while P. putida accounted for 54% of the 28 PSI patients. The most commonly reported species E. aerogenes was not associated with any PNAs and it was isolated from only three cases of PSI and from seven UTI cases.

A few of these infections were triggered by accidental or atypical events (Table 5). E. amnigenus, E. asburiae and P. putida, P. agglomerans, Rhizobium spp., and S. fonticola infections were reported from six individuals involved in motor vehicle accidents (MVA) (129, 133, 143, 200, 249, 260). Three cases of P. agglomerans infections were attributed to (1) Hickman catheter contaminated with water from botanical garden (160), (2) puncture wound involving date palm tree thorn (70, 167), and (3) plant-product splinters (70, 167). One case of P. ananatis infection followed an ocular trauma with a rice husk (193). A case of Serratia fonticola infection resulted from a bear bite (258) (Table 5).

Table 5

OrganismInfectionUnusual event
Enterobacter amnigenusSkin and soft tissue infection (SSTI)Motor vehicle accident (MVA)
Enterobacter asburiaeSSTIAll-terrain vehicle crash
Pantoea/Enterobacter agglomeransBlood stream infection (BSI)Hickman catheter contaminatd with water from botanical garden
SSTIPuncture wound in foot, foreign body in wound (wood splinter, date palm thorn)
OthersPlant-product puncture (rose thorn, date palm tree thorn, wood splinters, lemon tree thorn, wood fence splinter), contamination of catheter with non-sterile surface, worked in garden
Pantoea ananatisOthersOcular trauma with rice husk
Pseudomonas putidaBSIMVA
Post-surgical infection (PSI)Blast injuries, MVA with esophageal perforation
SSTIBlast injuries
OthersFall
Rahnella aquatilisBSIIV injection of contaminated D5W + Vit B complex outside hospital
Rhizobium spp.BSIContamination of CVC line due to exposure to soil, MVA
OthersPerforated duodenal ulcer
Serratia fonticolaBSIMVA
SSTIBear bite, MVA
OthersThorn penetration

Unusual events leading to infection by saprophytic Gram-negative bacteria species.

The isolates from the reported human infections exhibited a large repertoire of antimicrobial drug resistance (Table 6). In addition to resistance to earlier generation beta-lactam drugs, there were E. aerogenes, E. amnigenus, E. ludwigii, and P. agglomerans strains that were resistant to extended-spectrum beta-lactam drugs mediated by CTX-M, TEM, SHV, and OXA. Some of the E. aerogenes, E. amnigenus, E. asburiae, and P. putida strains expressed carbapenem resistance encoded by blaKPC and blaVIM. E. aerogenes and P. putida were the only GNB species that expressed IMP-1, a metallo-beta-lactamase, first described in Serratia marcescens in Japan (9), also found in Pseudomonas aeruginosa causing human infections (11).

Table 6

OrganismFluoroquinolonesAminoglycosidesEarly generation cephalosporinsBroad-spectrum cephalosporinsEarly generation penicillinsAnti-pseudomonal penicillinsTrimethoprim-sulfamethoxazoleTetracyclinesMacrolidesMetallo-beta-lactamsOthersDrug-resistance genes
Enterobacter aerogenes✓✓✓✓✓✓✓✓✓✓✓bla-TEM: TEM-1, TEM-3, TEM-20, TEM-24, TEM-116
bla-SHV: SHV-4, SHV-5, SHV-12, SHV-154
bla-CTX-M: CTX-M-1, CTX-M-2, CTX-M-3, CTX-M-9, CTX-M-14, CTX-M-15, CTX-M-24, CTX-M-59, CTX-M-group 1, CTX-M-group 9,
bla-OXA: OXA-1, OXA-48
bla-VIM: VIM-1, VIM-2
bla-DHA-1, bla-IMP-1
bla-KPC: KPC-2, KPC-3
AmpC
qnrB7-like, intI1, intl3, qnrS, tet(A) Class 1 integron, qacDE, sul1, qnrs-1, aac(6′)-Ib, qnrA1, qnrB4, qnrB6, qnrB8, aph(3)-Ia, sul3, dfrA12, aac(6′)-Ib-cr, aacA4–catB8–aadA1, ant(3″)-Ih–aac(6)-Iid–catB8, dfrA12–orfF–aadA2, dfrA5, ramA, oqxAB, efflux pump (AcrA, TolC, OmpA, OmpX, OmpE36, PAβN), chloramphenicol efflux pump
Enterobacter amnigenus✓✓✓✓✓✓✓bla-KPC-2, bla-TEM-1, bla-SHV-12, rmtB
bla-CTX-M: CTX-M-3, CTX-M-14
Enterobacter asburiae✓✓✓✓✓✓✓✓✓bla-KPC-2, bla-TEM-1, ARC-4, dfrA1, dfrA14, tet(A) Class 1 and 2 integrons, qacDE, sul1
Enterobacter kobei✓✓✓
Enterobacter ludwigii✓✓✓✓✓✓✓✓bla-OXA: OXA-2, OXA-48, CTX-M-15
Pantoea/Enterobacter agglomerans✓✓✓✓✓✓✓✓✓CTX-M-15, TEM-1, dfrA14, tet(K), qnrB1, aac-(69)-lb-cr, class 1 and 2 integron, aph, aadA1, cat1, qacDE, sul1
Pantoea ananatis
Pseudomonas putida✓✓✓✓✓✓✓✓✓✓bla-OXA: OXA-2, OXA-10
bla-VIM: VIM-1, VIM-2, VIM-4, VIM-5
bla-KPC: KPC-2
bla-IMP: IMP-1, IMP-9, IMP-12, IMP-15, IMP-16
bla-PER
blaPSE
VEB-1-like
plasmids, class 1 integron, class 3 integron, Tn402-like transposon, aacA4, orfD, qacEΔ1/sul, aadA1, aacA7, qacEΔ1, aphA15, arr-6 (rifampin), aadB, aac6, aadA2
Rahnella aquatilis✓✓✓✓bla-RHAN-1
Rhizobium✓✓✓✓✓✓✓
Serratia fonticola✓✓✓
Serratia proteamaculans✓✓✓✓✓

Drug-resistance and resistance genes of saprophytic Gram-negative bacteria species causing infection.

In addition to expressing beta-lactamases, these GNB species expressed resistance to many other classes of antimicrobial agents, including trimethoprim-sulfamethoxazole, aminoglycosides, fluoroquinolones, polymyxin, tetracyclines, rifampicin, macrolides, and chloramphenicol. Many of these resistance phenotypes were encoded by genes on mobile elements, including plasmids and integrons (Table 6).

Interestingly, some types of drug resistance co-segregated with GNB species. No ESBLs (CTX-M, SHV, TEM) were reported to be expressed by any of the P. putida strains, while few species other than P. putida expressed IMP metallo-beta-lactamases.

Discussion

The bibliographic search covering a period from the 1990s to 2014 revealed that human infections caused by saprophytic GNB found in the environment are not uncommon. Of course, exact sources of these saprophytes that caused the infections cannot be garnered from this type of review. These 20 GNB species were targeted for this review because they were frequently found on retail spinach, which are exposed to such species environmentally.

This search most likely underestimates the true incidence since such infections are not routinely and easily diagnosed in most hospitals. An isolation of a saprophyte from a clinical sample may be discounted as a contaminant. Nevertheless, the analyses of the reports reveal several common features of these infections: (1) they are distributed worldwide, (2) they occur almost exclusively in people with underlying comorbidities or HCA interventions who come into contact with environmental sources, (3) each GNB species has a distinct predilection for a site of infection, (4) they exhibit a wide spectrum of antimicrobial drug resistance, (5) they harbor drug-resistance genes identical to those commonly carried by recognized or primary human bacterial pathogens, and (6) drug-resistance gene types co-segregate with specific GNB saprophytic species.

Both case series and hospital microbiology surveys have shown that the most commonly reported GNB species was Enterobacter aerogenes (Table 1). It was most frequently associated with BSI. Its high frequency worldwide could classify this bacterial species as an opportunistic pathogen rather than a saprophyte, similar to the way Acinetobacter baumannii, also an environmental GNB, has come to be considered an opportunistic pathogen. It was the 12th most common BSI GNB isolate in a recent study from a public hospital in San Francisco (269).

Another Enterobacter spp., E. absuriae was the most common cause of UTI and PNA among the 13 saprophytic GNB species. The UTI was associated with prostate cancer in one patient (142), and patients with PNA had other underlying medical conditions, including cachexia and possible HIV infection (137). The Enterobacter spp. are environmental saprophytes. Why this particular Enterobacter spp. and not others are associated with UTI and PNA is not known. Furthermore, no infections were reported to be caused by 7 of the 20 saprophytic species (Table 1).

One major concern with these GNB organisms is their association with HCA infections. These organisms carry drug-resistance genes typically found in human primary GNB pathogens. In fact, two of these species—E. aerogenes and Pantoea agglomerans – carried the most common and globally distributed ESBL gene blaCTX-M-15, found in the most common pandemic ExPEC lineage ST131 (17, 270). Other studies have found drug-resistance genes harbored by bacterial pathogens in environmental saprophytic organisms (12, 271, 272). Although we found no evidence that such drug-resistance genes are transferred from these saprophytes to GNB pathogens, they appear to be more ubiquitous across saprophytes than previously recognized.

There are several limitations to this type of bibliographic search. Quantitative comparison of the GNB species and their frequency of infections and associations with comorbidities or medical interventions could not be accurately performed, since not all reports included comparable data. Systematic or population-based surveys of these GNB organisms have not been conducted in many places, so our summary of the frequencies of the species and their association with infections could have been biased by a small number of reports. Nevertheless, the search has shown that these saprophytic GNB do cause infections, particularly in people with comorbidities, and that they harbor a large repertoire of drug-resistance genes.

Acinetobacter baumannii, which first began to appear in hospitals worldwide in the 1970s (273, 274), has recently become the most common non-fermentative HCA pathogen in many hospitals in Latin America, surpassing P. aeruginosa (3). In the United States, it accounts for about 3% of HCA infections, and is currently the second most common non-fermentative organism after P. aeruginosa in most hospitals (2). GNB have been a frequent cause of HCA infections for many decades, but the proportion of such infections caused by multidrug-resistant strains and new species have steadily increased in the last 20 years worldwide. It is possible that the same factors that facilitated the first appearance and subsequent endemicity of A. baumannii in healthcare institutions could contribute to the introduction and establishment of other environmental saprophytic GNB into hospitals. With ever-expanding use of immunosuppressive drugs and biologics, invasive procedures, and increased prevalence of patients with chronic medical conditions as well as advanced age, these saprophytic GNB infections are likely to increase. Hospitals need to be prepared to detect these organisms, especially in infections in which recognized pathogens are not recovered. This work also sheds light on the role of antibiotics used in animal husbandry. Such use can select for antimicrobial drug resistance in commensal bacteria in animal intestines as well as in saprophytes in the environment with ramifications for human health as demonstrated by this study.

Statements

Author contributions

LR conceived the idea for this systematic review, based on previous work performed by ER. ER conducted the literature review, selected the publications for inclusion in the final analyses, and analyzed the data together with LR. ER wrote the first draft, which was reviewed by LR, and both authors reviewed multiple drafts to write the final draft.

Acknowledgments

This review was partly supported by RB Roberts Fund for drug-resistant bacterial infection research. We thank Arnaud Prusak for assisting with bibliographic retrieval and archiving the retrieved documents for our review.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supplementary material

The Supplementary Material for this article can be found online at http://www.frontiersin.org/article/10.3389/fmed.2017.00183/full#supplementary-material.

References

  • 1

    Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Atlanta: Centers for Disease Control and Prevention (2013).

  • 2

    HidronAIEdwardsJRPatelJHoranTCSievertDMPollockDAet alNHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol (2008) 29(11):996–1011.10.1086/591861

  • 3

    LunaCMRodriguez-NoriegaEBavestrelloLGuzman-BlancoM. Gram-negative infections in adult intensive care units of latin america and the Caribbean. Crit Care Res Pract (2014) 2014:480463.10.1155/2014/480463

  • 4

    WoodfordNTiernoPMJrYoungKTysallLPalepouMFWardEet alOutbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother (2004) 48(12):4793–9.10.1128/AAC.48.12.4793-4799.2004

  • 5

    NordmannPCuzonGNaasT. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis (2009) 9(4):228–36.10.1016/S1473-3099(09)70054-4

  • 6

    KumarasamyKKTolemanMAWalshTRBagariaJButtFBalakrishnanRet alEmergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis (2010) 10(9):597–602.10.1016/S1473-3099(10)70143-2

  • 7

    PitoutJDNordmannPLauplandKBPoirelL. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother (2005) 56(1):52–9.10.1093/jac/dki166

  • 8

    CoqueTMBaqueroFCantonR. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill (2008) 13(47):19044.

  • 9

    OsanoEArakawaYWacharotayankunROhtaMHoriiTItoHet alMolecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother (1994) 38(1):71–8.10.1128/AAC.38.1.71

  • 10

    LaurettiLRiccioMLMazzariolACornagliaGAmicosanteGFontanaRet alCloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother (1999) 43(7):1584–90.

  • 11

    LeeKLeeWGUhYHaGYChoJChongY. VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis (2003) 9(7):868–71.10.3201/eid0907.030012

  • 12

    RaphaelEWongLKRileyLW. Extended-spectrum Beta-lactamase gene sequences in gram-negative saprophytes on retail organic and nonorganic spinach. Appl Environ Microbiol (2011) 77(5):1601–7.10.1128/AEM.02506-10

  • 13

    PitoutJDLauplandKB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis (2008) 8(3):159–66.10.1016/S1473-3099(08)70041-0

  • 14

    CoqueTMNovaisACarattoliAPoirelLPitoutJPeixeLet alDissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis (2008) 14(2):195–200.10.3201/eid1402.070350

  • 15

    JohnsonJRJohnstonBClabotsCKuskowskiMACastanheiraM. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis (2010) 51(3):286–94.10.1086/653932

  • 16

    PeiranoGPitoutJD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents (2010) 35(4):316–21.10.1016/j.ijantimicag.2009.11.003

  • 17

    Nicolas-ChanoineMHBlancoJLeflon-GuiboutVDemartyRAlonsoMPCanicaMMet alIntercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother (2008) 61(2):273–81.10.1093/jac/dkm464

  • 18

    LinTYChiHWWangNC. Pathological fracture of the right distal radius caused by Enterobacter aerogenes osteomyelitis in an adult. Am J Med Sci (2010) 339(5):493–4.10.1097/MAJ.0b013e3181d94f90

  • 19

    AschbacherRPaganiLDoumithMPikeRWoodfordNSpoladoreGet alMetallo-beta-lactamases among Enterobacteriaceae from routine samples in an Italian tertiary-care hospital and long-term care facilities during 2008. Clin Microbiol Infect (2011) 17(2):181–9.10.1111/j.1198-743X.2010.03225.x

  • 20

    UtrupTRMuellerEWHealyDPCallcutRAPetersonJDHurfordWE. High-dose ciprofloxacin for serious gram-negative infection in an obese, critically ill patient receiving continuous venovenous hemodiafiltration. Ann Pharmacother (2010) 44(10):1660–4.10.1345/aph.1P234

  • 21

    KasapMFashaeKTorolSKolayliFBudakFVahabogluH. Characterization of ESBL (SHV-12) producing clinical isolate of Enterobacter aerogenes from a tertiary care hospital in Nigeria. Ann Clin Microbiol Antimicrob (2010) 9:1.10.1186/1476-0711-9-1

  • 22

    ChenHZhangYChenYGYuYSZhengSSLiLJ. Sepsis resulting from Enterobacter aerogenes resistant to carbapenems after liver transplantation. Hepatobiliary Pancreat Dis Int (2009) 8(3):320–2.

  • 23

    LeeSJWeonYCChaHJKimSYSeoKWJegalYet alA case of atypical skull base osteomyelitis with septic pulmonary embolism. J Korean Med Sci (2011) 26(7):962–5.10.3346/jkms.2011.26.7.962

  • 24

    RodriguesLNevesMMachadoSSaHMacarioFAlvesRet alUncommon cause of chest pain in a renal transplantation patient with autosomal dominant polycystic kidney disease: a case report. Transplant Proc (2012) 44(8):2507–9.10.1016/j.transproceed.2012.07.014

  • 25

    DieneSMMerhejVHenryMEl FilaliARouxVRobertCet alThe rhizome of the multidrug-resistant Enterobacter aerogenes genome reveals how new “killer bugs” are created because of a sympatric lifestyle. Mol Biol Evol (2013) 30(2):369–83.10.1093/molbev/mss236

  • 26

    CoreaEMBandaraPL. Isolation of inducible amp C beta-lactamase producing Enterobacter aerogenes from a diabetic foot ulcer. Ceylon Med J (2010) 55(3):95.10.4038/cmj.v55i3.2298

  • 27

    TorresELopez-CereroLDel ToroMDPascualA. First detection and characterization of an OXA-48-producing Enterobacter aerogenes isolate. Enferm Infecc Microbiol Clin (2014) 32(7):469–70.10.1016/j.eimc.2013.10.008

  • 28

    ZanationAFleischmanDChavalaSH. Ptosis, erythema, and rapidly decreasing vision. JAMA (2013) 309(22):2382–3.10.1001/jama.2013.5517

  • 29

    KatoMKaiseMObataTYonezawaJToyoizumiHYoshimuraNet alBacteremia and endotoxemia after endoscopic submucosal dissection for gastric neoplasia: pilot study. Gastric Cancer (2012) 15(1):15–20.10.1007/s10120-011-0050-4

  • 30

    IwalokunBAOluwadunAAkinsindeKANiemoghaMTNwaokorieFO. Bacteriologic and plasmid analysis of etiologic agents of conjunctivitis in Lagos, Nigeria. J Ophthalmic Inflamm Infect (2011) 1(3):95–103.10.1007/s12348-011-0024-z

  • 31

    KavaBRKanagarajahPAyyathuraiR. Contemporary revision penile prosthesis surgery is not associated with a high risk of implant colonization or infection: a single-surgeon series. J Sex Med (2011) 8(5):1540–6.10.1111/j.1743-6109.2011.02222.x

  • 32

    Rodriguez-VillalobosHBogaertsPBerhinCBauraingCDeplanoAMontesinosIet alTrends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother (2011) 66(1):37–47.10.1093/jac/dkq388

  • 33

    RischMRadjenovicDHanJNWydlerMNydeggerURischL. Comparison of MALDI TOF with conventional identification of clinically relevant bacteria. Swiss Med Wkly (2010) 140:w13095.10.4414/smw.2010.13095

  • 34

    SongEHParkKHJangEYLeeEJChongYPChoOHet alComparison of the clinical and microbiologic characteristics of patients with Enterobacter cloacae and Enterobacter aerogenes bacteremia: a prospective observation study. Diagn Microbiol Infect Dis (2010) 66(4):436–40.10.1016/j.diagmicrobio.2009.11.007

  • 35

    VogelaersDDe BelsDForetFCranSGilbertESchoonheydtKet alPatterns of antimicrobial therapy in severe nosocomial infections: empiric choices, proportion of appropriate therapy, and adaptation rates – a multicentre, observational survey in critically ill patients. Int J Antimicrob Agents (2010) 35(4):375–81.10.1016/j.ijantimicag.2009.11.015

  • 36

    NovaisABaqueroFMachadoECantonRPeixeLCoqueTM. International spread and persistence of TEM-24 is caused by the confluence of highly penetrating enterobacteriaceae clones and an IncA/C2 plasmid containing Tn1696:Tn1 and IS5075-Tn21. Antimicrob Agents Chemother (2010) 54(2):825–34.10.1128/AAC.00959-09

  • 37

    CanoMERodriguez-MartinezJMAgueroJPascualACalvoJGarcia-LoboJMet alDetection of plasmid-mediated quinolone resistance genes in clinical isolates of Enterobacter spp. in Spain. J Clin Microbiol (2009) 47(7):2033–9.10.1128/JCM.02229-08

  • 38

    DealENMicekSTReichleyRMRitchieDJ. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Clin Ther (2009) 31(2):299–310.10.1016/j.clinthera.2009.02.015

  • 39

    LiuWChenLLiHDuanHZhangYLiangXet alNovel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J Antimicrob Chemother (2009) 63(5):895–900.10.1093/jac/dkp068

  • 40

    DoumithMEllingtonMJLivermoreDMWoodfordN. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother (2009) 63(4):659–67.10.1093/jac/dkp029

  • 41

    MoeharioLHTjoaEKiranasariANingsihIRosanaYKaruniawatiA. Trends in antimicrobial susceptibility of gram-negative bacteria isolated from blood in Jakarta from 2002 to 2008. J Infect Dev Ctries (2009) 3(11):843–8.

  • 42

    ChangEPChiangDHLinMLChenTLWangFDLiuCY. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia. J Microbiol Immunol Infect (2009) 42(4):329–35.

  • 43

    DropaMBalsalobreLCLincopanNLincopanEMMurakamiTMCassettariVCet alExtended-spectrum beta-lactamases among Enterobacteriaceae isolated in a public hospital in Brazil. Rev Inst Med Trop São Paulo (2009) 29(5):518–27.10.1590/s0036-46652009000400005

  • 44

    TanejaNRaoPAroraJDograA. Occurrence of ESBL & Amp-C beta-lactamases & susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res (2008) 127(1):85–8.

  • 45

    SouliMKontopidouFVPapadomichelakisEGalaniIArmaganidisAGiamarellouH. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital. Clin Infect Dis (2008) 46(6):847–54.10.1086/528719

  • 46

    LockhartSRAbramsonMABeekmannSEGallagherGRiedelSDiekemaDJet alAntimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol (2007) 45(10):3352–9.10.1128/JCM.01284-07

  • 47

    AibinuIPfeiferYPetersFOgunsolaFAdenipekunEOdugbemiTet alEmergence of bla(CTX-M-15), qnrB1 and aac(6’)-Ib-cr resistance genes in Pantoea agglomerans and Enterobacter cloacae from Nigeria (sub-Saharan Africa). J Med Microbiol (2012) 61(Pt 1):165–7.10.1099/jmm.0.035238-0

  • 48

    Al-TawfiqJAAntonyAAbedMS. Antimicrobial resistance rates of Enterobacter spp.: a seven-year surveillance study. Med Princ Pract (2009) 18(2):100–4.10.1159/000189806

  • 49

    AnastayMLagierEBlancVChardonH. [Epidemiology of extended spectrum beta-lactamases (ESBL) Enterobacteriaceae in a General Hospital, South of France, 1999-2007]. Pathol Biol (2013) 61(2):38–43.10.1016/j.patbio.2012.03.001

  • 50

    WalktyAAdamHJLaverdiereMKarlowskyJAHobanDJZhanelGGet alIn vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study. Diagn Microbiol Infect Dis (2011) 69(3):348–55.10.1016/j.diagmicrobio.2010.10.032

  • 51

    KanamoriHNavarroRBYanoHSombreroLTCapedingMRLupisanSPet alMolecular characteristics of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae from the Philippines. Acta Trop (2011) 120(1–2):140–5.10.1016/j.actatropica.2011.07.007

  • 52

    ZhangRCaiJCZhouHWNasuMChenGX. Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems. J Med Microbiol (2011) 60(Pt 12):1813–9.10.1099/jmm.0.025668-0

  • 53

    LavigneJPSottoANicolas-ChanoineMHBouzigesNBourgGDavin-RegliAet alMembrane permeability, a pivotal function involved in antibiotic resistance and virulence in Enterobacter aerogenes clinical isolates. Clin Microbiol Infect (2012) 18(6):539–45.10.1111/j.1469-0691.2011.03607.x

  • 54

    Rodriguez-MartinezJMFernandez-EchauriPFernandez-CuencaFDiaz de AlbaPBrialesAPascualA. Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo. J Antimicrobial Chemotherapy (2012) 67(1):64–8.10.1093/jac/dkr423

  • 55

    JeongHSBaeIKShinJHJungHJKimSHLeeJYet alPrevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae. Korean J Lab Med (2011) 31(4):257–64.10.3343/kjlm.2011.31.4.257

  • 56

    RuizEOcampo-SosaAAAlcoba-FlorezJRomanEArletGTorresCet alChanges in ciprofloxacin resistance levels in Enterobacter aerogenes isolates associated with variable expression of the aac(6’)-Ib-cr gene. Antimicrob Agents Chemother (2012) 56(2):1097–100.10.1128/AAC.05074-11

  • 57

    HellerIGrifKOrthD. Emergence of VIM-1-carbapenemase-producing Enterobacter cloacae in Tyrol, Austria. J Med Microbiol (2012) 61(Pt 4):567–71.10.1099/jmm.0.038646-0

  • 58

    ChengNCLiuCYHuangYTLiaoCHTengLJHsuehPR. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam. J Antimicrob Chemother (2012) 67(6):1413–21.10.1093/jac/dks042

  • 59

    WuKWangFSunJWangQChenQYuSet alClass 1 integron gene cassettes in multidrug-resistant Gram-negative bacteria in southern China. Int J Antimicrob Agents (2012) 40(3):264–7.10.1016/j.ijantimicag.2012.05.017

  • 60

    CarbonneAArnaudIMaugatSMartyNDumartinCBertrandXet alNational multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J Antimicrob Chemother (2013) 68(4):954–9.10.1093/jac/dks464

  • 61

    LavigneJPSottoANicolas-ChanoineMHBouzigesNPagesJMDavin-RegliA. An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates. Int J Antimicrob Agents (2013) 41(2):130–6.10.1016/j.ijantimicag.2012.10.010

  • 62

    VelebaMDe MajumdarSHornseyMWoodfordNSchneidersT. Genetic characterization of tigecycline resistance in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Antimicrob Chemother (2013) 68(5):1011–8.10.1093/jac/dks530

  • 63

    TrivediMPatelVSomanRRodriguezCSinghalT. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials. J Assoc Physicians India (2012) 60:28–30.

  • 64

    Nogueira KdaSPaganiniMCConteACogoLLTaborda de Messias ReasonIda SilvaMJet alEmergence of extended-spectrum beta-lactamase producing Enterobacter spp. in patients with bacteremia in a tertiary hospital in southern Brazil. Enferm Infecc Microbiol Clin (2014) 32(2):87–92.10.1016/j.eimc.2013.02.004

  • 65

    ShengWHBadalREHsuehPRProgramS. Distribution of extended-spectrum beta-lactamases, AmpC beta-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for monitoring antimicrobial resistance trends (SMART). Antimicrob Agents Chemother (2013) 57(7):2981–8.10.1128/AAC.00971-12

  • 66

    GhobrialGMThakkarVAndrewsELangMChitaleAOppenlanderMEet alIntraoperative vancomycin use in spinal surgery: single institution experience and microbial trends. Spine (2014) 39(7):550–5.10.1097/BRS.0000000000000241

  • 67

    HobanDJBadalRBouchillonSHackelMKazmierczakKLascolsCet alIn vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011. Diagn Microbiol Infect Dis (2014) 79(3):367–72.10.1016/j.diagmicrobio.2014.03.026

  • 68

    HuhKKangCIKimJChoSYHaYEJooEJet alRisk factors and treatment outcomes of bloodstream infection caused by extended-spectrum cephalosporin-resistant Enterobacter species in adults with cancer. Diagn Microbiol Infect Dis (2014) 78(2):172–7.10.1016/j.diagmicrobio.2013.11.002

  • 69

    KarlowskyJAAdamHJBaxterMRLagace-WiensPRWalktyAJHobanDJet alIn vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance study. Antimicrob Agents Chemother (2013) 57(11):5600–11.10.1128/AAC.01485-13

  • 70

    VaimanMLazarovichTLotanG. Pantoea agglomerans as an indicator of a foreign body of plant origin in cases of wound infection. J Wound Care (2013) 22(4):184–5.10.12968/jowc.2013.22.4.182

  • 71

    ChenLChavdaKDMelanoRGJacobsMRKollBHongTet alComparative genomic analysis of KPC-encoding pKpQIL-like plasmids and their distribution in New Jersey and New York Hospitals. Antimicrob Agents Chemother (2014) 58(5):2871–7.10.1128/AAC.00120-14

  • 72

    MishraMPDebataNKPadhyRN. Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian. Asian Pac J Trop Biomed (2013) 3(4):315–24.10.1016/s2221-1691(13)60071-4

  • 73

    AhnCSyedAHuFO’HaraJARiveraJIDoiY. Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital system. Diagn Microbiol Infect Dis (2014) 80(2):154–8.10.1016/j.diagmicrobio.2014.06.010

  • 74

    PenaIPicazoJJRodriguez-AvialCRodriguez-AvialI. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents (2014) 43(5):460–4.10.1016/j.ijantimicag.2014.01.021

  • 75

    KuaiSShaoHHuangLPeiHLuZWangWet alKPC-2 carbapenemase and DHA-1 AmpC determinants carried on the same plasmid in Enterobacter aerogenes. J Med Microbiol (2014) 63(Pt 3):367–70.10.1099/jmm.0.054627-0

  • 76

    LuoYYangJYeLGuoLZhaoQChenRet alCharacterization of KPC-2-producing Escherichia coli, Citrobacter freundii, Enterobacter cloacae, Enterobacter aerogenes, and Klebsiella oxytoca isolates from a Chinese Hospital. Microb Drug Resist (2014) 20(4):264–9.10.1089/mdr.2013.0150

  • 77

    GarbatiMABin AbdulhakABabaKSakkijhaH. Infection due to colistin-resistant Enterobacteriaceae in critically-ill patients. J Infect Dev Ctries (2013) 7(10):713–9.10.3855/jidc.2851

  • 78

    JainRWalkSTAronoffDMYoungVBNewtonDWChenowethCEet alEmergence of Carbapenemaseproducing Klebsiella pneumoniae of sequence type 258 in Michigan, USA. Infect Dis Rep (2013) 5(1):e5.10.4081/idr.2013.e5

  • 79

    MarkovskaRDStoevaTJBojkovaKDMitovIG. Epidemiology and molecular characterization of extended-spectrum beta-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens isolates from a Bulgarian hospital. Microb Drug Resist (2014) 20(2):131–7.10.1089/mdr.2013.0102

  • 80

    KangozhinovaKAbentayevaBRepaABaltabayevaAErwaWStaufferF. Culture proven newborn sepsis with a special emphasis on late onset sepsis caused by Enterobacteriaceae in a level III neonatal care unit in Astana, Kazakhstan. Wien Klin Wochenschr (2013) 125(19–20):611–5.10.1007/s00508-013-0416-1

  • 81

    BalkanIIAygunGAydinSMutcaliSIKaraZKuskucuMet alBlood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival. Int J Infect Dis (2014) 26:51–6.10.1016/j.ijid.2014.05.012

  • 82

    NovaisARodriguesCBranquinhoRAntunesPGrossoFBoaventuraLet alSpread of an OmpK36-modified ST15 Klebsiella pneumoniae variant during an outbreak involving multiple carbapenem-resistant Enterobacteriaceae species and clones. Eur J Clin Microbiol Infect Dis (2012) 31(11):3057–63.10.1007/s10096-012-1665-z

  • 83

    NarayanSAKoolJLVakololomaMSteerACMejiaADrakeAet alInvestigation and control of an outbreak of Enterobacter aerogenes bloodstream infection in a neonatal intensive care unit in Fiji. Infect Control Hosp Epidemiol (2009) 30(8):797–800.10.1086/598240

  • 84

    BhatSSUndrakondaVMukhopadhyayCParmarPV. Outbreak of multidrug-resistant acute postoperative endophthalmitis due to Enterobacter aerogenes. Ocul Immunol Inflamm (2014) 22(2):121–6.10.3109/09273948.2013.830752

  • 85

    AkhtarNAlqurashiAMAbu TwibahM. In vitro ciprofloxacin resistance profiles among gram-negative bacteria isolated from clinical specimens in a teaching hospital. J Pak Med Assoc (2010) 60(8):625–7.

  • 86

    AndersonBNicholasSSpragueBCamposJShortBSinghN. Molecular and descriptive epidemiologyof multidrug-resistant Enterobacteriaceae in hospitalized infants. Infect Control Hosp Epidemiol (2008) 29(3):250–5.10.1086/527513

  • 87

    BaskinEOzcayFSakalliHAgrasPIKarakayaliHCananOet alFrequency of urinary tract infection in pediatric liver transplantation candidates. Pediatr Transplant (2007) 11(4):402–7.10.1111/j.1399-3046.2006.00674.x

  • 88

    BiendoMCanarelliBThomasDRousseauFHamdadFAdjideCet alSuccessive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital. J Clin Microbiol (2008) 46(3):1037–44.10.1128/JCM.00197-07

  • 89

    BrasmeLNordmannPFidelFLartigueMFBajoletOPoirelLet alIncidence of class A extended-spectrum beta-lactamases in Champagne-Ardenne (France): a 1 year prospective study. J Antimicrob Chemother (2007) 60(5):956–64.10.1093/jac/dkm319

  • 90

    ChenCYHansenKSHansenLK. Rhizobium radiobacter as an opportunistic pathogen in central venous catheter-associated bloodstream infection: case report and review. J Hosp Infect (2008) 68(3):203–7.10.1016/j.jhin.2007.11.021

  • 91

    ChenYGZhangYYuYSQuTTWeiZQShenPet alIn vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases. Int J Antimicrob Agents (2008) 32(4):302–7.10.1016/j.ijantimicag.2008.02.014

  • 92

    ChevalierJMulfingerCGarnotelENicolasPDavin-RegliAPagesJM. Identification and evolution of drug efflux pump in clinical Enterobacter aerogenes strains isolated in 1995 and 2003. PLoS One (2008) 3(9):e3203.10.1371/journal.pone.0003203

  • 93

    Cohen StuartJMoutonJWDiederenBMAl NaiemiNThijsenSVlaminckxBJet alEvaluation of Etest to determine tigecycline MICs for Enterobacter species. Antimicrob Agents Chemother (2010) 54(6):2746–7.10.1128/AAC.01726-09

  • 94

    DealENMicekSTRitchieDJReichleyRMDunneWMJrKollefMH. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii. Pharmacotherapy (2007) 27(2):191–9.10.1592/phco.27.2.191

  • 95

    DhakalSManandharSShresthaBDhakalRPudasainiM. Extended spectrum beta-lactamase producing multidrug resistant urinary isolates from children visiting Kathmandu Model Hospital. Nepal Med Coll J (2012) 14(2):136–41.

  • 96

    DiPersioJRDowzickyMJ. Regional variations in multidrug resistance among Enterobacteriaceae in the USA and comparative activity of tigecycline, a new glycylcycline antimicrobial. Int J Antimicrob Agents (2007) 29(5):518–27.10.1016/j.ijantimicag.2006.10.019

  • 97

    GalasMDecousserJWBretonNGodardTAllouchPYPinaPet alNationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France. Antimicrob Agents Chemother (2008) 52(2):786–9.10.1128/AAC.00906-07

  • 98

    GhisalbertiDMahamoudAChevalierJBaiticheMMartinoMPagesJMet alChloroquinolines block antibiotic efflux pumps in antibiotic-resistant Enterobacter aerogenes isolates. Int J Antimicrob Agents (2006) 27(6):565–9.10.1016/j.ijantimicag.2006.03.010

  • 99

    Giraud-MorinCFosseT. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)]. Pathol Biol (2008) 56(7–8):417–23.10.1016/j.patbio.2008.07.003

  • 100

    GoethaertKVan LooverenMLammensCJansensHBaraniakAGniadkowskiMet alHigh-dose cefepime as an alternative treatment for infections caused by TEM-24 ESBL-producing Enterobacter aerogenes in severely-ill patients. Clin Microbiol Infect (2006) 12(1):56–62.10.1111/j.1469-0691.2005.01290.x

  • 101

    HorianopoulouMLegakisNJKanellopoulouMLambropoulosSTsakrisAFalagasME. Frequency and predictors of colonization of the respiratory tract by VIM-2-producing Pseudomonas aeruginosa in patients of a newly established intensive care unit. J Med Microbiol (2006) 55(Pt 10):1435–9.10.1099/jmm.0.46713-0

  • 102

    WangJHLeeBJJangYJ. Bacterial coinfection and antimicrobial resistance in patients with paranasal sinus fungus balls. Ann Otol Rhinol Laryngol (2010) 119(6):406–11.10.1177/000348941011900608

  • 103

    LangPOJehlFBerthelMKaltenbachG. [Microbial description of bacteriuria in long-term care facilities: a prospective study in the French Teaching Hospital of Strasbourg]. Med Mal Infect (2006) 36(5):280–4.10.1016/j.medmal.2005.12.010

  • 104

    KhatriBBasnyatSKarkiAPoudelAShresthaB. Etiology and antimicrobial susceptibility pattern of bacterial pathogens from urinary tract infection. Nepal Med Coll J (2012) 14(2):129–32.

  • 105

    PinaPPangonBRioYChardonHLallaliAKAllouchPY. [Antibiotic sensitivity of enterobacteria in intensive care units]. Pathol Biol (2000) 48(5):485–9.

  • 106

    ParkYJYuJKLeeSOhEJWooGJ. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea. J Antimicrob Chemother (2007) 60(4):868–71.10.1093/jac/dkm266

  • 107

    OtajevwoFD. Urinary tract infection among symptomatic outpatients visiting a tertiary hospital based in midwestern Nigeria. Glob J Health Sci (2013) 5(2):187–99.10.5539/gjhs.v5n2p187

  • 108

    MartinezDRodulfoHERodriguezLCanaLEMedinaBGuzmanMet alFirst report of metallo-beta-lactamases producing Enterobacter spp. strains from Venezuela. Rev Inst Med Trop Sao Paulo (2014) 56(1):67–9.10.1590/S0036-46652014000100010

  • 109

    MachadoECoqueTMCantonRNovaisASousaJCBaqueroFet alHigh diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother (2007) 60(6):1370–4.10.1093/jac/dkm381

  • 110

    VonbergRPWolterAKolaAZiesingSGastmeierP. The endemic situation of Enterobacter aerogenes and Enterobacter cloacae: you will only discover what you are looking for. J Hosp Infect (2007) 65(4):372–4.10.1016/j.jhin.2006.12.010

  • 111

    TsakrisAPoulouAThemeli-DigalakiKVoulgariEPittarasTSofianouDet alUse of boronic acid disk tests to detect extended-spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae. J Clin Microbiol (2009) 47(11):3420–6.10.1128/JCM.01314-09

  • 112

    SchumacherASteinkePBohnertJAAkovaMJonasDKernWV. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother (2006) 57(2):344–8.10.1093/jac/dki446

  • 113

    SundaramVKumarPDuttaSMukhopadhyayKRayPGautamVet alBlood culture confirmed bacterial sepsis in neonates in a North Indian tertiary care center: changes over the last decade. Jpn J Infect Dis (2009) 62(1):46–50.

  • 114

    RyanRJLindsellCSheehanP. Fluoroquinolone resistance during 2000-2005: an observational study. BMC Infect Dis (2008) 8:71.10.1186/1471-2334-8-71

  • 115

    WongMRDel RossoPHeineLVolpeVLeeLKornblumJet alAn outbreak of Klebsiella pneumoniae and Enterobacter aerogenes bacteremia after interventional pain management procedures, New York City, 2008. Reg Anesth Pain Med (2010) 35(6):496–9.10.1097/AAP.0b013e3181fa1163

  • 116

    BilgenHOzekEUnverTBiyikliNAlpayHCebeciD. Urinary tract infection and hyperbilirubinemia. Turk J Pediatr (2006) 48(1):51–5.

  • 117

    CunhaBAMcDermottBNausheenS. Single daily high-dose tigecycline therapy of a multidrug-resistant (MDR) Klebsiella pneumoniae and Enterobacter aerogenes nosocomial urinary tract infection. J Chemother (2007) 19(6):753–4.10.1179/joc.2007.19.6.753

  • 118

    EdouardSSaillerLSagotCMunschCAstudilloLArletP. [A painful thumb]. La Revue de Médecine Interne (2010) 31(10):712–3.10.1016/j.revmed.2009.12.015

  • 119

    GhoshJMurrayDKhwajaNMurphyMOHalkaAWalkerMG. Late infection of an endovascular stent graft with septic embolization, colonic perforation, and aortoduodenal fistula. Ann Vasc Surg (2006) 20(2):263–6.10.1007/s10016-006-9006-2

  • 120

    Laguna-del EstalPGarcia-MonteroPAgud-FernandezMLopez-Cano GomezMCastaneda-PastorAGarcia-ZubiriC. [Bacterial meningitis due to gram-negative bacilli in adults]. Rev Neurol (2010) 50(8):458–62.

  • 121

    ParkerRGulRBucknallVBowleyDKarandikarS. Double jeopardy: pyogenic liver abscess and massive secondary rectal haemorrhage after rubber band ligation of haemorrhoids. Colorectal Dis (2011) 13(7):e184.10.1111/j.1463-1318.2010.02387.x

  • 122

    OndoundaMTanonAEhuiEOuattaraIKassiAAbaYTet al[Two cases of Fanconi’s syndrome induced by tenofovir in the Ivory Coast]. Med Mal Infect (2011) 41(2):105–7.10.1016/j.medmal.2010.07.009

  • 123

    WunderlichCAKrachLE. Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study. Dev Med Child Neurol (2006) 48(6):450–5.10.1017/S0012162206000971

  • 124

    Van EndeCTintillierMCuvelierCMigaliGPochetJM. Intraperitoneal meropenem administration: a possible alternative to the intravenous route. Perit Dial Int (2010) 30(2):250–1.10.3747/pdi.2009.00052

  • 125

    van der MeerWStephen ScottCVerlaatCGunnewiekJKWarrisA. Measurement of neutrophil membrane CD64 and HLA-Dr in a patient with abdominal sepsis. J Infect (2006) 53(1):e43–6.10.1016/j.jinf.2005.09.003

  • 126

    SmithTGoldschlagerTMottNRobertsonTCampbellS. Optic atrophy due to Curvularia lunata mucocoele. Pituitary (2007) 10(3):295–7.10.1007/s11102-007-0012-3

  • 127

    SantanaLCaceresJJSanchez-PalaciosMCasamitjanaA. [Acute renal failure associated with severe falciparum malaria]. Nefrologia (2006) 26(6):751–2.

  • 128

    RondinaMTRaphaelKPendletonRSandeMA. Abdominal aortitis due to Streptococcus pneumoniae and Enterobacter aerogenes: a case report and review. J Gen Intern Med (2006) 21(7):C1–3.10.1111/j.1525-1497.2006.00455.x

  • 129

    CortiGMondanelliNLoscoMBartoliniLFontanelliAParadisiF. Post-traumatic infection of the lower limb caused by rare Enterobacteriaceae and Mucorales in a young healthy male. Int J Infect Dis (2009) 13(2):e57–60.10.1016/j.ijid.2008.06.029

  • 130

    WesterfeldCPapaliodisGNBehlauIDurandMLSobrinL. Enterobacter amnigenus endophthalmitis. Retin Cases Brief Rep (2009) 3(4):409–11.10.1097/ICB.0b013e31818a46c0

  • 131

    ShengJFLiJJTuSShengZKBiSZhuMHet alblaKPC and rmtB on a single plasmid in Enterobacter amnigenus and Klebsiella pneumoniae isolates from the same patient. Eur J Clin Microbiol Infect Dis (2012) 31(7):1585–91.10.1007/s10096-011-1481-x

  • 132

    KorahSBraganzaAJacobPBalajiV. An “epidemic” of post cataract surgery endophthalmitis by a new organism. Indian J Ophthalmol (2007) 55(6):464–6.10.4103/0301-4738.36486

  • 133

    BolletCElkoubyAPietriPde MiccoP. Isolation of Enterobacter amnigenus from a heart transplant recipient. Eur J Clin Microbiol Infect Dis (1991) 10(12):1071–3.10.1007/BF01984933

  • 134

    BolletCGainnierMSaintyJMOrhesserPDe MiccoP. Serratia fonticola isolated from a leg abscess. J Clin Microbiol (1991) 29(4):834–5.

  • 135

    JanDBerlieCBabinG. [Fatal posttransfusion Enterobacter amnigenus septicemia]. Presse Med (1999) 28(18):965.

  • 136

    CapdevilaJABisbeVGasserIZuazuJOliveTFernandezFet al[Enterobacter amnigenus. An unusual human pathogen]. Enferm Infecc Microbiol Clin (1998) 16(8):364–6.

  • 137

    StewartJMQuirkJR. Community-acquired pneumonia caused by Enterobacter asburiae. Am J Med (2001) 111(1):82–3.10.1016/S0002-9343(01)00791-4

  • 138

    KangCIKimSHParkWBLeeKDKimHBOhMDet alBloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis (2004) 39(6):812–8.10.1086/423382

  • 139

    ToftelandSNaseerULislevandJHSundsfjordASamuelsenO. A long-term low-frequency hospital outbreak of KPC-producing Klebsiella pneumoniae involving intergenus plasmid diffusion and a persisting environmental reservoir. PLoS One (2013) 8(3):e59015.10.1371/journal.pone.0059015

  • 140

    StockIGrugerTWiedemannB. Natural antibiotic susceptibility of strains of the Enterobacter cloacae complex. Int J Antimicrob Agents (2001) 18(6):537–45.10.1016/S0924-8579(01)00463-0

  • 141

    PitoutJDMolandESSandersCCThomsonKSFitzsimmonsSR. Beta-lactamases and detection of beta-lactam resistance in Enterobacter spp. Antimicrob Agents Chemother (1997) 41(1):35–9.

  • 142

    BrennerDJMcWhorterACKaiASteigerwaltAGFarmerJJIII. Enterobacter asburiae sp. nov., a new species found in clinical specimens, and reassignment of Erwinia dissolvens and Erwinia nimipressuralis to the genus Enterobacter as Enterobacter dissolvens comb. nov. and Enterobacter nimipressuralis comb. nov. J Clin Microbiol (1986) 23(6):1114–20.

  • 143

    KothKBonifaceJChanceEAHanesMC. Enterobacter asburiae and Aeromonas hydrophila: soft tissue infection requiring debridement. Orthopedics (2012) 35(6):e996–9.10.3928/01477447-20120525-52

  • 144

    HoffmannHSchmoldtSTrulzschKStumpfABengschSBlankensteinTet alNosocomial urosepsis caused by Enterobacter kobei with aberrant phenotype. Diagn Microbiol Infect Dis (2005) 53(2):143–7.10.1016/j.diagmicrobio.2005.06.008

  • 145

    HoffmannHStindlSStumpfAMehlenAMongetDHeesemannJet alDescription of Enterobacter ludwigii sp. nov., a novel Enterobacter species of clinical relevance. Syst Appl Microbiol (2005) 28(3):206–12.10.1016/j.syapm.2004.12.009

  • 146

    MokrackaJKoczuraRPawlowskiKKaznowskiA. Resistance patterns and integron cassette arrays of Enterobacter cloacae complex strains of human origin. J Med Microbiol (2011) 60(Pt 6):737–43.10.1099/jmm.0.027979-0

  • 147

    KosakoYTamuraKSakazakiRMikiK. Enterobacter kobei sp. nov., a new species of the family Enterobacteriaceae resembling Enterobacter cloacae. Curr Microbiol (1996) 33(4):261–5.10.1007/s002849900110

  • 148

    KhajuriaAPraharajAKGroverNKumarM. First report of an Enterobacter ludwigii isolate coharboring NDM-1 and OXA-48 carbapenemases. Antimicrob Agents Chemother (2013) 57(10):5189–90.10.1128/AAC.00789-13

  • 149

    O’HaraCMSteigerwaltAGHillBCMillerJMBrennerDJ. First report of a human isolate of Erwinia persicinus. J Clin Microbiol (1998) 36(1):248–50.

  • 150

    Morales RuizJEspinosa AguilarMDLopez GarridoMANogueras LopezFVinolo UbinaC. [Pantoea agglomerans bacteriemia in a liver transplant patient]. Rev Esp Enferm Dig (2010) 102(1):61–2.

  • 151

    HarrisEJ. Retained Hawthorn fragment in a child’s foot complicated by infection: diagnosis and excision aided by localization with ultrasound. J Foot Ankle Surg (2010) 49(2):161–5.10.1053/j.jfas.2009.08.012

  • 152

    BorrasMRoigJGarciaMFernandezE. Adverse effects of pantoea peritonitis on peritoneal transport. Perit Dial Int (2009) 29(2):234–5.

  • 153

    DuerinckxJF. Case report: subacute synovitis of the knee after a rose thorn injury: unusual clinical picture. Clin Orthop Relat Res (2008) 466(12):3138–42.10.1007/s11999-008-0482-2

  • 154

    LimPSChenSLTsaiCYPaiMA. Pantoea peritonitis in a patient receiving chronic ambulatory peritoneal dialysis. Nephrology (2006) 11(2):97–9.10.1111/j.1440-1797.2006.00552.x

  • 155

    CicchettiRIacobiniMMidullaFPapoffPMancusoMMorettiC. Pantoea agglomerans sepsis after rotavirus gastroenteritis. Pediatr Infect Dis J (2006) 25(3):280–1.10.1097/01.inf.0000202211.64017.c6

  • 156

    LalasKMErichsenD. Sporadic Pantoea agglomerans bacteremia in a near-term female: case report and review of literature. Jpn J Infect Dis (2010) 63(4):290–1.

  • 157

    AlyNYSalmeenHNLilaRANagarajaPA. Pantoea agglomerans bloodstream infection in preterm neonates. Med Princ Pract (2008) 17(6):500–3.10.1159/000151575

  • 158

    SeokSJangYJLeeSWKimHCHaGY. A case of bilateral endogenous Pantoea agglomerans endophthalmitis with interstitial lung disease. Korean J Ophthalmol (2010) 24(4):249–51.10.3341/kjo.2010.24.4.249

  • 159

    BachmeyerCEntressengleHGibeaultMNedellecGM’BappePDelisleFet alBilateral tibial chronic osteomyelitis due to Pantoea agglomerans in a patient with sickle cell disease. Rheumatology (2007) 46(8):1247.10.1093/rheumatology/kem127

  • 160

    RussellKWaghornDDeviR. The potential perils of a visit to botanical gardens in a patient with a central intravascular device. J Hosp Infect (2007) 66(4):402–4.10.1016/j.jhin.2007.05.003

  • 161

    BergmanKAArendsJPScholvinckEH. Pantoea agglomerans septicemia in three newborn infants. Pediatr Infect Dis J (2007) 26(5):453–4.10.1097/01.inf.0000261200.83869.92

  • 162

    FullertonDGLwinAALalS. Pantoea agglomerans liver abscess presenting with a painful thigh. Eur J Gastroenterol Hepatol (2007) 19(5):433–5.10.1097/MEG.0b013e3280ad4414

  • 163

    HsiehCTLiangJSPengSSLeeWT. Seizure associated with total parenteral nutrition-related hypermanganesemia. Pediatr Neurol (2007) 36(3):181–3.10.1016/j.pediatrneurol.2006.10.005

  • 164

    UcheA. Pantoea agglomerans bacteremia in a 65-year-old man with acute myeloid leukemia: case report and review. South Med J (2008) 101(1):102–3.10.1097/SMJ.0b013e31815d3ca6

  • 165

    MagnetteCTintillierMHorlaitGCuvelierCPochetJM. Severe peritonitis due to Pantoea agglomerans in a CCPD patient. Perit Dial Int (2008) 28(2):207–8.

  • 166

    NahaKRamamoorthiPrabhuM. Spontaneous septicaemia with multi – organ dysfunction – a new face for Pantoe agglomerans?Asian Pac J Trop Med (2012) 5(1):83–4.10.1016/s1995-7645(11)60252-6

  • 167

    RaveOAssousMVHashkesPJLebelEHadas-HalpernIMeggedO. Pantoea agglomerans foreign body-induced septic arthritis. Pediatr Infect Dis J (2012) 31(12):1311–2.10.1097/INF.0b013e31826fd434

  • 168

    FerrantinoMNavaneethanSDSloandJA. Pantoea agglomerans: an unusual inciting agent in peritonitis. Perit Dial Int (2008) 28(4):428–30.

  • 169

    HabhabWBlakePG. Pantoea peritonitis: not just a “thorny” problem. Perit Dial Int (2008) 28(4):430.

  • 170

    ShubovAJagannathanPChin-HongPV. Pantoea agglomerans pneumonia in a heart-lung transplant recipient: case report and a review of an emerging pathogen in immunocompromised hosts. Transpl Infect Dis (2011) 13(5):536–9.10.1111/j.1399-3062.2011.00630.x

  • 171

    GranglGGallistlSLeschnikBMunteanW. Port-A-Cath infection causes inhibitor recurrence after initial successful ITI. Haemophilia (2013) 19(3):e174–5.10.1111/hae.12103

  • 172

    KazanciogluRBuyukaydinBIrazMAlayMErkocR. An unusual cause of peritonitis in peritoneal dialysis patients: Pantoea agglomerans. J Infect Dev Ctries (2014) 8(7):919–22.10.3855/jidc.3785

  • 173

    KletkeSNBrissetteARGaleJ. Endogenous bacterial endophthalmitis caused by Pantoea species: a case report. Can J Ophthalmol (2014) 49(1):e1–2.10.1016/j.jcjo.2013.09.004

  • 174

    Fernandez-MunozHLassalettaAGonzalezMJAndionMMaderoL. Pantoea agglomerans bacteremia in a child with acute lymphoblastic leukemia during induction therapy. J Pediatr Hematol Oncol (2015) 37(4):328.10.1097/MPH.0000000000000190

  • 175

    HischebethGTKohlhofHWimmerMDRandauTMBekeredjian-DingIGraviusS. Detection of Pantoea agglomerans in hip prosthetic infection by sonication of the removed prosthesis: the first reported case. Technol Health Care (2013) 21(6):613–8.10.3233/THC-130757

  • 176

    KahveciAAsiciogluETigenEAriEArikanHOdabasiZet alUnusual causes of peritonitis in a peritoneal dialysis patient: Alcaligenes faecalis and Pantoea agglomerans. Ann Clin Microbiol Antimicrob (2011) 10:12.10.1186/1476-0711-10-12

  • 177

    DepsPD. Scalp abscess due to Enterobacter agglomerans. Int J Dermatol (2006) 45(4):482–3.10.1111/j.1365-4632.2005.02618.x

  • 178

    VolkschBThonSJacobsenIDGubeM. Polyphasic study of plant- and clinic-associated Pantoea agglomerans strains reveals indistinguishable virulence potential. Infect Genet Evol (2009) 9(6):1381–91.10.1016/j.meegid.2009.09.016

  • 179

    KenchappaPRaoKRAhmedNJoshiSGhousunnissaSVijayalakshmiVet alFluorescent amplified fragment length polymorphism (FAFLP) based molecular epidemiology of hospital infections in a tertiary care setting in Hyderabad, India. Infect Genet Evol (2006) 6(3):220–7.10.1016/j.meegid.2005.05.003

  • 180

    GoncalvesMOCoutinho-FilhoWPPimentaFPPereiraGAPereiraJAMattos-GuaraldiALet alPeriodontal disease as reservoir for multi-resistant and hydrolytic enterobacterial species. Lett Appl Microbiol (2007) 44(5):488–94.10.1111/j.1472-765X.2007.02111.x

  • 181

    CruzATCazacuACAllenCH. Pantoea agglomerans, a plant pathogen causing human disease. J Clin Microbiol (2007) 45(6):1989–92.10.1128/JCM.00632-07

  • 182

    Flores PopocaEOMiranda GarciaMRomero FigueroaSMendoza MedellinASandoval TrujilloHSilva RojasHVet alPantoea agglomerans in immunodeficient patients with different respiratory symptoms. ScientificWorldJournal (2012) 2012:156827.10.1100/2012/156827

  • 183

    LibertoMCMateraGPuccioRLo RussoTColosimoEFocaE. Six cases of sepsis caused by Pantoea agglomerans in a teaching hospital. New Microbiol (2009) 32(1):119–23.

  • 184

    BicudoELMacedoVOCarraraMACastroFFRageRI. Nosocomial outbreak of Pantoea agglomerans in a pediatric urgent care center. Braz J Infect Dis (2007) 11(2):281–4.10.1590/S1413-86702007000200023

  • 185

    BoszczowskiINobrega de AlmeidaJJrPeixoto de MirandaEJPinheiro FreireMGuimaraesTChavesCEet alNosocomial outbreak of Pantoea agglomerans bacteraemia associated with contaminated anticoagulant citrate dextrose solution: new name, old bug?J Hosp Infect (2012) 80(3):255–8.10.1016/j.jhin.2011.12.006

  • 186

    ChenKJChenTHSueYM. Citrobacter youngae and Pantoea agglomerans peritonitis in a peritoneal dialysis patient. Perit Dial Int (2013) 33(3):336–7.10.3747/pdi.2012.00151

  • 187

    LabiancaLMontanaroATurturroFCalderaroCFerrettiA. Osteomyelitis caused by Pantoea agglomerans in a closed fracture in a child. Orthopedics (2013) 36(2):e252–6.10.3928/01477447-20130122-32

  • 188

    Moreiras-PlazaMBlanco-GarciaRRomero-JungPFeijoo-PineiroDFernandez-FernandezCAmmariI. Pantoea agglomerans: the gardener’s peritonitis?Clin Nephrol (2009) 72(2):159–61.10.5414/CNP72159

  • 189

    Marcos SanchezFMunoz RuizAIMartin BarrancoMJViana AlonsoA. [Bacteremia caused by Pantoea agglomerans]. An Med Interna (2006) 23(5):250–1.

  • 190

    WongKW. Pantoea agglomerans as a rare cause of catheter-related infection in hemodialysis patients. J Vasc Access (2013) 14(3):306.10.5301/jva.5000139

  • 191

    RodriguesALLimaIKKouryAJrde SousaRMMeguinsLC. Pantoea agglomerans liver abscess in a resident of Brazilian Amazonia. Trop Gastroenterol (2009) 30(3):154–5.

  • 192

    De BaereTVerhelstRLabitCVerschraegenGWautersGClaeysGet alBacteremic infection with Pantoea ananatis. J Clin Microbiol (2004) 42(9):4393–5.10.1128/JCM.42.9.4393-4395.2004

  • 193

    ManoharanGLalithaPJeganathanLPDsilvaSSPrajnaNV. Pantoea ananatis as a cause of corneal infiltrate after rice husk injury. J Clin Microbiol (2012) 50(6):2163–4.10.1128/JCM.06743-11

  • 194

    SialaMGdouraRFouratiHRihlMJaulhacBYounesMet alBroad-range PCR, cloning and sequencing of the full 16S rRNA gene for detection of bacterial DNA in synovial fluid samples of Tunisian patients with reactive and undifferentiated arthritis. Arthritis Res Ther (2009) 11(4):R102.10.1186/ar2748

  • 195

    De MaayerPChanWYRezzonicoFBuhlmannAVenterSNBlomJet alComplete genome sequence of clinical isolate Pantoea ananatis LMG 5342. J Bacteriol (2012) 194(6):1615–6.10.1128/JB.06715-11

  • 196

    YoshinoYKitazawaTKamimuraMTatsunoKOtaYYotsuyanagiH. Pseudomonas putida bacteremia in adult patients: five case reports and a review of the literature. J Infect Chemother (2011) 17(2):278–82.10.1007/s10156-010-0114-0

  • 197

    TrevinoMMoldesLHernandezMMartinez-LamasLGarcia-RiestraCRegueiroBJ. Nosocomial infection by VIM-2 metallo-beta-lactamase-producing Pseudomonas putida. J Med Microbiol (2010) 59(Pt 7):853–5.10.1099/jmm.0.018036-0

  • 198

    CarpenterRJHartzellJDForsbergJABabelBSGanesanA. Pseudomonas putida war wound infection in a US Marine: a case report and review of the literature. J Infect (2008) 56(4):234–40.10.1016/j.jinf.2008.01.004

  • 199

    DervisogluEDundarDOYegenagaIWillkeA. Peritonitis due to Pseudomonas putida in a patient receiving automated peritoneal dialysis. Infection (2008) 36(4):379–80.10.1007/s15010-007-6349-8

  • 200

    PoirelLYakupogullariYKizirgilADogukanMNordmannP. VIM-5 metallo-beta-lactamase-producing Pseudomonas putida from Turkey. Int J Antimicrob Agents (2009) 33(3):287.10.1016/j.ijantimicag.2008.07.018

  • 201

    ToruSMaruyamaTHoriTGochoNKobayashiT. Pseudomonous putida meningitis in a healthy adult. J Neurol (2008) 255(10):1605–6.10.1007/s00415-008-0987-3

  • 202

    ThomasBSOkamotoKBankowskiMJSetoTB. A lethal case of bacteremia due to soft tissue infection. Infect Dis Clin Prac (2013) 21(3):147–213.10.1097/IPC.0b013e318276956b

  • 203

    ZuberbuhlerBCarifiG. Pseudomonas putida infection of the conjunctiva. Infection (2012) 40(5):579–80.10.1007/s15010-012-0248-3

  • 204

    AlmeidaACVilelaMACavalcantiFLMartinsWMMoraisMAJrMoraisMM. First description of KPC-2-producing Pseudomonas putida in Brazil. Antimicrob Agents Chemother (2012) 56(4):2205–6.10.1128/AAC.05268-11

  • 205

    RokickaM. AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation. Acta Biomed (2006) 77(Suppl 2):26–7.

  • 206

    Ying-ChengLChao-KungLKo-HuaCWen-MingH. Daytime orthokeratology associated with infectious keratitis by multiple gram-negative bacilli: Burkholderia cepacia, Pseudomonas putida, and Pseudomonas aeruginosa. Eye Contact Lens (2006) 32(1):19–20.10.1097/01.icl.0000167714.53847.8c

  • 207

    PatzerJAWalshTRWeeksJDzierzanowskaDTolemanMA. Emergence and persistence of integron structures harbouring VIM genes in the Children’s Memorial Health Institute, Warsaw, Poland, 1998-2006. J Antimicrob Chemother (2009) 63(2):269–73.10.1093/jac/dkn512

  • 208

    JuanCZamoranoLMenaAAlbertiSPerezJLOliverA. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. J Antimicrob Chemother (2010) 65(3):474–8.10.1093/jac/dkp491

  • 209

    MendesRECastanheiraMTolemanMASaderHSJonesRNWalshTR. Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6’)-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital. Antimicrob Agents Chemother (2007) 51(7):2611–4.10.1128/AAC.00838-06

  • 210

    ShahSSKagenJLautenbachEBilkerWBMatroJDominguezTEet alBloodstream infections after median sternotomy at a children’s hospital. J Thorac Cardiovasc Surg (2007) 133(2):435–40.10.1016/j.jtcvs.2006.09.026

  • 211

    RossoliniGMLuzzaroFMigliavaccaRMugnaioliCPiniBDe LucaFet alFirst countrywide survey of acquired metallo-beta-lactamases in gram-negative pathogens in Italy. Antimicrob Agents Chemother (2008) 52(11):4023–9.10.1128/AAC.00707-08

  • 212

    LeeKParkAJKimMYLeeHJChoJHKangJOet alMetallo-beta-lactamase-producing Pseudomonas spp. in Korea: high prevalence of isolates with VIM-2 type and emergence of isolates with IMP-1 type. Yonsei Med J (2009) 50(3):335–9.10.3349/ymj.2009.50.3.335

  • 213

    MitsudaYTakeshimaYMoriTYanaiTHayakawaAMatsuoM. Utility of multiplex PCR in detecting the causative pathogens for pediatric febrile neutropenia. Kobe J Med Sci (2011) 57(2):E32–7.

  • 214

    JacquierHCarbonnelleECorvecSIlliaquerMLe MonnierABilleEet alRevisited distribution of nonfermenting Gram-negative bacilli clinical isolates. Eur J Clin Microbiol Infect Dis (2011) 30(12):1579–86.10.1007/s10096-011-1263-5

  • 215

    BogaertsPHuangTDRodriguez-VillalobosHBauraingCDeplanoAStruelensMJet alNosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-beta-lactamases. J Antimicrob Chemother (2008) 61(3):749–51.10.1093/jac/dkm529

  • 216

    Carvalho-AssefAPGomesMZSilvaARWerneckLRodriguesCASouzaMJet alIMP-16 in Pseudomonas putida and Pseudomonas stutzeri: potential reservoirs of multidrug resistance. J Med Microbiol (2010) 59(Pt 9):1130–1.10.1099/jmm.0.020487-0

  • 217

    AlmuzaraMRadiceMde GarateNKossmanACuiroloASantellaGet alVIM-2-producing Pseudomonas putida, Buenos Aires. Emerg Infect Dis (2007) 13(4):668–9.10.3201/eid1304.061083

  • 218

    KimSEParkSHParkHBParkKHKimSHJungSIet alNosocomial Pseudomonas putida bacteremia: high rates of carbapenem resistance and mortality. Chonnam Med J (2012) 48(2):91–5.10.4068/cmj.2012.48.2.91

  • 219

    GilarranzRJuanCCastillo-VeraJChamizoFJArtilesFAlamoIet alFirst detection in Europe of the metallo-beta-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa. Clin Microbiol Infect (2013) 19(9):E424–7.10.1111/1469-0691.12248

  • 220

    OguzSSUnluSSayganSDilliDErdoganBDilmenU. Rapid control of an outbreak of Pseudomonas putida in a tertiary neonatal intensive care unit. J Hosp Infect (2010) 76(4):361–2.10.1016/j.jhin.2010.07.013

  • 221

    Souza DiasMBHabertABBorrascaVStempliukVCiolliAAraujoMRet alSalvage of long-term central venous catheters during an outbreak of Pseudomonas putida and Stenotrophomonas maltophilia infections associated with contaminated heparin catheter-lock solution. Infect Control Hosp Epidemiol (2008) 29(2):125–30.10.1086/526440

  • 222

    AumeranCPaillardCRobinFKanoldJBaudOBonnetRet alPseudomonas aeruginosa and Pseudomonas putida outbreak associated with contaminated water outlets in an oncohaematology paediatric unit. J Hosp Infect (2007) 65(1):47–53.10.1016/j.jhin.2006.08.009

  • 223

    LiuYLiuKYuXLiBCaoB. Identification and control of a Pseudomonas spp (P. fulva and P. putida) bloodstream infection outbreak in a teaching hospital in Beijing, China. Int J Infect Dis (2014) 23:105–8.10.1016/j.ijid.2014.02.013

  • 224

    CarinderJEChuaJDCoralesRBTaegeAJProcopGW. Rahnella aquatilis bacteremia in a patient with relapsed acute lymphoblastic leukemia. Scand J Infect Dis (2001) 33(6):471–3.10.1080/00365540152029972

  • 225

    ErolSZencirogluADilliDOkumusNAydinMGolNet alEvaluation of nosocomial blood stream infections caused by Pseudomonas species in newborns. Clin Lab (2014) 60(4):615–20.10.7754/Clin.Lab.2013.130325

  • 226

    CaroffNChamouxCLe GallouFEspazeEGaviniFGautreauDet alTwo epidemiologically related cases of Rahnella aquatilis bacteremia. Eur J Clin Microbiol Infect Dis (1998) 17(5):349–52.10.1007/s100960050080

  • 227

    ReinaJLopezA. Clinical and microbiological characteristics of Rahnella aquatilis strains isolated from children. J Infect (1996) 33(2):135–7.10.1016/S0163-4453(96)93138-2

  • 228

    MatsukuraHKatayamaKKitanoNKobayashiKKaneganeCHiguchiAet alInfective endocarditis caused by an unusual gram-negative rod, Rahnella aquatilis. Pediatr Cardiol (1996) 17(2):108–11.10.1007/BF02505093

  • 229

    FunkeGRosnerH. Rahnella aquatilis bacteremia in an HIV-infected intravenous drug abuser. Diagn Microbiol Infect Dis (1995) 22(3):293–6.10.1016/0732-8893(95)00100-O

  • 230

    MarakiSSamonisGMarnelakisETselentisY. Surgical wound infection caused by Rahnella aquatilis. J Clin Microbiol (1994) 32(11):2706–8.

  • 231

    HoppeJEHerterMAleksicSKlingebielTNiethammerD. Catheter-related Rahnella aquatilis bacteremia in a pediatric bone marrow transplant recipient. J Clin Microbiol (1993) 31(7):1911–2.

  • 232

    AlballaaSRQadriSMal-FurayhOal-QataryK. Urinary tract infection due to Rahnella aquatilis in a renal transplant patient. J Clin Microbiol (1992) 30(11):2948–50.

  • 233

    TashK. Rahnella aquatilis bacteremia from a suspected urinary source. J Clin Microbiol (2005) 43(5):2526–8.10.1128/JCM.43.5.2526-2528.2005

  • 234

    GaitanJIBronzeMS. Infection caused by Rahnella aquatilis. Am J Med Sci (2010) 339(6):577–9.10.1097/MAJ.0b013e3181dd0cca

  • 235

    ChangCLJeongJShinJHLeeEYSonHC. Rahnella aquatilis sepsis in an immunocompetent adult. J Clin Microbiol (1999) 37(12):4161–2.

  • 236

    BellaisSPoirelLFortineauNDecousserJWNordmannP. Biochemical-genetic characterization of the chromosomally encoded extended-spectrum class A beta-lactamase from Rahnella aquatilis. Antimicrob Agents Chemother (2001) 45(10):2965–8.10.1128/AAC.45.10.2965-2968.2001

  • 237

    GoubauPVan AelstFVerhaegenJBoogaertsM. Septicaemia caused by Rahnella aquatilis in an immunocompromised patient. Eur J Clin Microbiol Infect Dis (1988) 7(5):697–9.10.1007/BF01964261

  • 238

    DhatariyaKGoodayCMorrowDMurchisonRTurnerJHutchinsonRet alRhizobium radiobacter wound infection in a patient with diabetes – fact, factitious or just plain unlucky?QJM (2012) 105(4):365–8.10.1093/qjmed/hcr045

  • 239

    Erol CipeFDoguFSucuogluDAysevDIkinciogullariA. Asymptomatic catheter related Rhizobium radiobacter infection in a haploidentical hemapoetic stem cell recipient. J Infect Dev Ctries (2010) 4(8):530–2.10.3855/jidc.1009

  • 240

    SoodSNerurkarVMalvankarS. Catheter associated bloodstream infection caused by R. radiobacter. Indian J Med Microbiol (2010) 28(1):62–4.10.4103/0255-0857.58734

  • 241

    KatoJMoriTSugitaKAisaYIkedaYOkamotoS. Central line-associated bacteremia caused by Rhizobium radiobacter after allogeneic bone marrow transplantation. Transpl Infect Dis (2009) 11(4):380–1.10.1111/j.1399-3062.2009.00396.x

  • 242

    HanadaSIwamotoMKobayashiNAndoRSasakiS. Catheter-related bacteremia caused by Agrobacterium radiobacter in a hemodialysis patient. Intern Med (2009) 48(6):455–7.10.2169/internalmedicine.48.1754

  • 243

    DetraitMD’HondtLAndreMLonchayCHolemansXMatonJPet alAgrobacterium radiobacter bacteremia in oncologic and geriatric patients: presentation of two cases and review of the literature. Int J Infect Dis (2008) 12(6):e7–10.10.1016/j.ijid.2008.03.010

  • 244

    ChristakisGBAlexakiPAlivizatosASChalkiopoulouIAthanasiouAEZarkadisIK. Primary bacteraemia caused by Rhizobium radiobacter in a patient with solid tumours. J Med Microbiol (2006) 55(Pt 10):1453–6.10.1099/jmm.0.46411-0

  • 245

    KhanSAl-SweihNOthmanAHDharR. Bacteremia caused by Rhizobium radiobacter in a preterm neonate. Indian J Pediatr (2014) 81(2):191–2.10.1007/s12098-013-1012-0

  • 246

    RojasLOMartinezLFVivesCHLopezEACifuentesM. Cerebral abscess caused by Rhizobium radiobacter: first case report. AIDS (2012) 26(7):897–8.10.1097/QAD.0b013e3283528b3f

  • 247

    Moreau-GaudryVChiquetCBoissetSCroizeJBenitoYCornutPLet alThree cases of post-cataract surgery endophthalmitis due to Rhizobium (Agrobacterium) radiobacter. J Clin Microbiol (2012) 50(4):1487–90.10.1128/JCM.06106-11

  • 248

    KaselitzTBHariadiNILiPumaJJWeinbergJB. Rhizobium radiobacter bacteremia in a neonate. Infection (2012) 40(4):437–9.10.1007/s15010-011-0216-3

  • 249

    PonnapulaSSwansonJMWoodGCBoucherBAWellsDLCroceMAet alTreatment of Rhizobium radiobacter bacteremia in a critically ill trauma patient. Ann Pharmacother (2013) 47(11):1584–7.10.1177/1060028013500942

  • 250

    TsaiSF. Rhizobium radiobacter peritonitis revisited: catheter removal is not mandatory. Perit Dial Int (2013) 33(3):331–2.10.3747/pdi.2012.00134

  • 251

    RomanoLSpanuTCalistaFZappacostaBMignognaSSaliMet alTsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli. Clin Microbiol Infect (2011) 17(7):1049–52.10.1111/j.1469-0691.2010.03396.x

  • 252

    ChaoCMTsaiTCLaiCC. Secondary peritonitis due to Rhizobium radiobacter. Surg Infect (2014) 15(2):141–3.10.1089/sur.2012.168

  • 253

    GuerraNCNobreACravinoJ. Native mitral valve endocarditis due to Rhizobium radiobacter – first case report. Rev Port Cir Cardiotorac Vasc (2013) 20(4):203–5.

  • 254

    Karadag-OncelEOzsurekciYAytacSKaraACengizABCeyhanM. Implantable vascular access port-associated bloodstream infection caused by Rhizobium radiobacter: a case report. Turk J Pediatr (2013) 55(1):112–5.

  • 255

    Pinerua GonsalvezJFZambrano Infantinot RdelCCalcanoCMontanoCFuenmayorZRodneyHet al[Infective endocarditis by Rhizobium radiobacter. A case report]. Invest Clin (2013) 54(1):68–73.

  • 256

    MinguelaJIde-PablosMCastellanosTRuiz-de-GaunaR. Peritonitis by Rhizobium radiobacter. Perit Dial Int (2006) 26(1):112.

  • 257

    MantadakisEKondiAChristidouAKalmantiM. Agrobacterium radiobacter bacteremia in a child with acute lymphoblastic leukemia. World J Pediatr (2010) 6(2):181–4.10.1007/s12519-010-0018-1

  • 258

    KunimotoDRennieRCitronDMGoldsteinEJ. Bacteriology of a bear bite wound to a human: case report. J Clin Microbiol (2004) 42(7):3374–6.10.1128/JCM.42.7.3374-3376.2004

  • 259

    GorretJChevalierJGaschetAFraisseBViolasPChapuisMet alChildhood delayed septic arthritis of the knee caused by Serratia fonticola. Knee (2009) 16(6):512–4.10.1016/j.knee.2009.02.008

  • 260

    PfyfferGE. Serratia fonticola as an infectious agent. Eur J Clin Microbiol Infect Dis (1992) 11(2):199–200.10.1007/BF01967080

  • 261

    FarzanehSPeduzziJDemachyMCBarthelemyMLabiaR. [Identification of a cephalosporinase susceptible to clavulanic acid in a clinical strain of Serratia fonticola]. Pathol Biol (1995) 43(4):315–9.

  • 262

    BolletCGrimontPGainnierMGeisslerASaintyJMDe MiccoP. Fatal pneumonia due to Serratia proteamaculans subsp. quinovora. J Clin Microbiol (1993) 31(2):444–5.

  • 263

    TemoinSChakakiAAskariAEl-HalabyAFitzgeraldSMarcusREet alIdentification of oral bacterial DNA in synovial fluid of patients with arthritis with native and failed prosthetic joints. J Clin Rheumatol (2012) 18(3):117–21.10.1097/RHU.0b013e3182500c95

  • 264

    ChengALiuCYTsaiHYHsuMSYangCJHuangYTet alBacteremia caused by Pantoea agglomerans at a medical center in Taiwan, 2000-2010. J Microbiol Immunol Infect (2013) 46(3):187–94.10.1016/j.jmii.2012.05.005

  • 265

    ChristakisGBPerlorentzouSPAslanidouMSavvaLZarkadisIK. Bacteremia caused by Pantoea agglomerans and Enterococcus faecalis in a patient with colon cancer. J BUON (2007) 12(2):287–90.

  • 266

    KanamoriHYanoHHirakataYHirotaniAAraiKEndoSet alMolecular characteristics of extended-spectrum beta-lactamases and qnr determinants in Enterobacter species from Japan. PLoS One (2012) 7(6):e37967.10.1371/journal.pone.0037967

  • 267

    MarchiaroPVialeAMBalleriniVRossignolGVilaAJLimanskyA. First report of a Tn402-like class 1 integron carrying blaVIM-2 in Pseudomonas putida from Argentina. J Infect Dev Ctries (2010) 4(6):412–6.

  • 268

    QinXYangYHuFZhuD. Hospital clonal dissemination of Enterobacter aerogenes producing carbapenemase KPC-2 in a Chinese teaching hospital. J Med Microbiol (2014) 63(Pt 2):222–8.10.1099/jmm.0.064865-0

  • 269

    Adams-SapperSSergeevna-SeleznevaJTartofSRaphaelEDiepBAPerdreau-RemingtonFet alGlobally dispersed mobile drug-resistance genes in gram-negative bacterial isolates from patients with bloodstream infections in a US urban general hospital. J Med Microbiol (2012) 61(Pt 7):968–74.10.1099/jmm.0.041970-0

  • 270

    Nicolas-ChanoineMHBertrandXMadecJY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev (2014) 27(3):543–74.10.1128/CMR.00125-13

  • 271

    WrightGD. Antibiotic resistance in the environment: a link to the clinic?Curr Opin Microbiol (2010) 13(5):589–94.10.1016/j.mib.2010.08.005

  • 272

    BermanHFRileyLW. Identification of novel antimicrobial resistance genes from microbiota on retail spinach. BMC Microbiol (2013) 13:272.10.1186/1471-2180-13-272

  • 273

    PelegAYSeifertHPatersonDL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev (2008) 21(3):538–82.10.1128/CMR.00058-07

  • 274

    ZarrilliRPournarasSGiannouliMTsakrisA. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents (2013) 41(1):11–9.10.1016/j.ijantimicag.2012.09.008

Summary

Keywords

Gram-negative bacteria, saprophytes, drug-resistant Gram-negative bacteria, Enterobacter aerogenes, Pantoea agglomerans, Pseudomonas putida

Citation

Raphael E and Riley LW (2017) Infections Caused by Antimicrobial Drug-Resistant Saprophytic Gram-Negative Bacteria in the Environment. Front. Med. 4:183. doi: 10.3389/fmed.2017.00183

Received

04 September 2017

Accepted

12 October 2017

Published

30 October 2017

Volume

4 - 2017

Edited by

Nicola Petrosillo, Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani (IRCCS), Italy

Reviewed by

Stephanie J. Dancer, NHS Lanarkshire, United Kingdom; Aleksandra Barac, University of Belgrade, Serbia

Updates

Copyright

© 2017 Raphael and Riley.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Lee W. Riley,

†Present address: Eva Raphael, Department of Family and Community Medicine, University of California-San Francisco, San Francisco General Hospital, San Francisco, CA, United States

Specialty section: This article was submitted to Infectious Diseases – Surveillance, Prevention and Treatment, a section of the journal Frontiers in Medicine

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Share on WeChat

Scan with WeChat to share this article

Article metrics